Feature | SCAI | February 25, 2019| Subhash Banerjee, M.D., FSCAI, Abu-Fadel Mazen, M.D., FSCAI and Rajesh Swaminathan, M.D., FSCAI

Peripheral Vascular Track Highlighted at SCAI 2019

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. Henry Ford Hospital CTO case.

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. 

The track will include a blend of clinical challenges presented by emerging interventional stars and approaches to addressing them, which will be articulated and critiqued by expert panelists. The audience will be able to participate in discussion and share their expertise and experience. The program was changed from last year to move away from global overviews toward highly specific topics that will capture the burning issues in peripheral artery disease (PAD)

Peripheral live cases will offer an opportunity to see some of the most technically refined and engaging operators demonstrate their approach to complex endovascular cases. A professionally produced broadcast will highlight each movement and device manipulation, with commentary from a group of expert panelists. 

The track also includes multiple technically enriching sessions with a mix of "do’s and don’ts," as well as ways to bail out of trouble, end of the road options, and “my worst nightmare.” Designed to foster candid discussions on the execution of specific technical maneuvers and ways to improvise out of the box solutions, these sessions will provide an opportunity to engage colleagues over the details of technical execution and device selection. 

The exhibit hall technology exhibits will offer several hands-on displays so attendees can try wires and devices. Cases over cocktails in the exhibit hall will offer immersed learning, providing an opportunity to share informal commentary, friendly critique and candid self-assessment of skills and abilities. 

The goal track will take a step beyond minimally invasive arterial interventions. These sessions have been designed to carefully choreographed synergy between devices and medical interventions as the cornerstone for delivering effective and durable therapy to patients. This concept will be front and center during highly practical didactic sessions on polyvascular disease states, pulmonary embolism, stroke interventions, venous diseases, thrombophilia, antithrombotic drug therapies and more.

Finally, the SCAI 2019 Peripheral Vascular Track has made it a priority to showcase many talented and emerging new presenters from diverse backgrounds and specialties, whose accomplishments vastly surpass their youth and experience. 

For more information: http://www.scai.org/scai2019


Editor's note: The authors are the program directors for the peripheral vascular track at SCAI 2019. They include: 

Subhash Banerjee, M.D., FSCAI, is a professor of medicine at the University of Texas Southwestern Medical Center (UTSW) and also is the chief of cardiology at the VA North Texas Health Care System in Dallas.

Abu-Fadel Mazen, M.D., FSCAI, is director of interventional cardiology and cardiac cath lab at the University of Oklahoma Health Sciences Center.

Rajesh Swaminathan, M.D., FSCAI, is an associate professor of medicine at Duke University School of Medicine. 

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init